Neogen Corporation Other Noncash Income (Expense)
Neogen Corporation (NEOG) reported Other Noncash Income (Expense) of -$800.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-30
- Neogen Corporation other noncash income (expense) for the quarter ending 2026-05-31 was -$1.00M, a 140.00% decline year-over-year.
- Neogen Corporation other noncash income (expense) for the quarter ending 2026-02-28 was -$227.00K, a 682.05% decline year-over-year.
- Neogen Corporation other noncash income (expense) for the quarter ending 2025-11-30 was $45.00K.
- Neogen Corporation other noncash income (expense) for the quarter ending 2025-08-31 was $382.00K, a 46.36% increase year-over-year.
- Neogen Corporation other noncash income (expense) for fiscal 2026 was -$800.00K, a 128.57% decline from fiscal 2025.
- Neogen Corporation other noncash income (expense) for fiscal 2025 was $2.80M.
- Neogen Corporation other noncash income (expense) for fiscal 2024 was -$4.70M, a 786.13% decline from fiscal 2023.
- Neogen Corporation other noncash income (expense) for fiscal 2023 was $685.00K, a 71.91% decline from fiscal 2022.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$1.23M derived: sum of 2 quarters · filed 2026-07-30 | -$1.18M derived: sum of 3 quarters · filed 2026-07-30 | -$800.00K 10-K · filed 2026-07-30 | ||
| 2026-02-28 | -$227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | -$182.00K derived: sum of 2 quarters · filed 2026-04-09 | $200.00K 10-Q · filed 2026-04-09 | $2.70M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $427.00K 10-Q · filed 2026-01-08 | $2.93M derived: sum of 3 quarters · filed 2026-07-30 | $2.97M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | $382.00K 10-Q · filed 2025-10-09 | $2.88M derived: sum of 2 quarters · filed 2026-07-30 | $2.92M derived: sum of 3 quarters · filed 2026-07-30 | $2.92M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $2.54M derived: sum of 2 quarters · filed 2026-07-30 | $2.54M derived: sum of 3 quarters · filed 2026-07-30 | $2.80M 10-K · filed 2026-07-30 | $2.84M 10-K · filed 2025-07-30 | |
| 2025-02-28 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $39.00K derived: sum of 2 quarters · filed 2026-04-09 | $300.00K 10-Q · filed 2026-04-09 | $290.00K 10-Q · filed 2025-04-09 | -$4.47M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $261.00K 10-Q · filed 2026-01-08 | -$4.51M derived: sum of 3 quarters · filed 2026-07-30 | -$4.44M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | $261.00K 10-Q · filed 2025-10-09 | -$4.51M derived: sum of 2 quarters · filed 2026-07-30 | -$4.44M derived: sum of 3 quarters · filed 2026-07-30 | -$4.44M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-05-31 | -$4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$4.70M derived: sum of 2 quarters · filed 2026-07-30 | -$4.70M derived: sum of 3 quarters · filed 2026-07-30 | -$4.70M 10-K · filed 2026-07-30 | -$4.83M 10-K · filed 2024-07-30 | |
| 2024-02-29 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | $74.00K derived: sum of 2 quarters · filed 2025-04-09 | $74.00K 10-Q · filed 2025-04-09 | |||
| 2023-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | $0.00 10-Q · filed 2025-01-15 | ||||
| 2023-08-31 | $0.00 10-Q · filed 2024-10-10 | |||||
| 2023-05-31 | $685.00K 10-K · filed 2025-07-30 | |||||
| 2022-05-31 | $2.44M 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |